Recently, we have identified a hydroxyprolinecontaining protein(s) in human plasma (1) and developed a specific method for its assay (2) . The behavior of this protein (hyproprotein) as shown in precipitation and gel filtration experiments indicates that it is a large molecule; its resistance to digestion by proteolytic enzymes suggests further that it may be a form of collagen (2) . As part of a program of study to determine the significance and possible origin of this circulating protein, a survey was made of plasma hyproprotein levels in a large number of normal subjects and in patients with a variety of clinical disorders. Also, comparisons were made with the levels of excretion in the urine of hydroxyprolinecontaining peptides.
Methods
Subjects. These were 101 normal individuals and 146 patients with various diseases. The normal subjects ranged in age from newborn to 93 years. The newborns were from normal deliveries at the National Naval Medical Center, Bethesda, Md. Normal children and adolescents were either outpatients seen for routine checkup at the Navy Pediatric Clinic or volunteers from the Bethesda community. Normal adults in the 20-to 70-year age range were either employees or hospitalized volunteers at the National Institutes of Health; the 70-to 93-year age range was comprised of residents of a nursing home in the Bethesda area. The patients studied ranged in-age from 20 to 67 years and were seen at either the National Naval Medical Center or the National Institutes of Health.
Technique. Initially, blood samples from the antecubital veins of fasting subjects were drawn into .01 vol heparin (heparin sodium, 1,000 U.S.P. units per ml).
In later studies, the same relative amount of 40%o (wt/ vol) sodium citrate was used as discussed under Results. The blood was centrifuged at 40 C for 30 minutes at 1,000 X g, and the plasma was separated. Routinely the plasma proteins were precipitated immediately; occasionally the plasma was stored at -20°C for 1 to 3 days before assay.
Procedure. The procedure used for the assay of plasma hyproprotein (2) consists of precipitation of plasma proteins by cold ethanol, complete hydrolysis of the proteins by autoclaving overnight in alkali, separation of hydroxyproline from interfering materials by cation-exchange chromatography, and measurement of hydroxyproline by procedure II of Prockop and Udenfriend (3). The latter method was also used to measure urinary hydroxyproline. Urine for this determination was collected in acid while subjects were receiving a hydroxyproline-free diet that contained no meat, fish, gelatin, ice cream, or soft candies; ample protein was supplied by milk, eggs, and cheese.
Results
I. Conditions of plasma preparation. Heparin was used as the anticoagulant until it was realized that, after freezing and thawing, a material which contained hyproprotein was precipitated from heparinized plasma. In seven normal subjects and two subjects with elevated hyproprotein levels, the mean loss after 2 months at -200 C was 31 and 47%o, respectively. Approximately one-half of this loss could be accounted for by the hydroxyproline of the heparin-insoluble precipitates. These precipitates contained about six times as much hydroxyproline per milligram protein as was present in ethanol precipitates of the fresh plasma.
Subsequently, sodium citrate was used as anticoagulant. Hyproprotein in citrated plasma was found to be unchanged in ten normal samples and in ten samples with elevated levels after storage at -200 C for 3 months. The mechanism underlying the relative stability of the hyproprotein in citrate as compared with heparin was not investigated.
The possibility that the hyproprotein in plasma might arise by breakdown of cellular elements of the blood was studied. When whole blood was subjected to Diurnal variation and the effect of diet on plasma hyproprotein were studied in two normal young adult volunteers. As illustrated in Figure  1 , only minor variations of plasma hyproprotein levels were observed during 7 days on a regular hospital diet followed by 7 days on a hydroxyproline-free diet. Also, as shown in Figure 2 , no consistent variations were apparent in eight plasma samples collected at 3-hour intervals from each of two young adult subjects.
III. Plasma (Table II) . Also four patients with sarcomas that histologically were producing bone or cartilage had uniformly elevated levels as did a single patient with reticulum cell sarcoma. Elevations were seen in three patients with carcinoma of the breast; two of these had obvious metastases (including bone), and one had no clinical signs of metastatic disease. In six patients with carcinoid tumors and the carcinoid syndrome, elevations were observed only in the three patients in which the carcinoid heart lesion (4) was also present.
,X >- Elevations in plasma hyproprotein were also observed in febrile disorders of a diverse etiology and renal disease with azotemia and early uremia. Evidence for the presence or absence of fever or renal impairment was sought in the other disorders studied. With the exception of the patients included under Inflammatory and Febrile Disease (Table II, no. 3), no subjects had evidence of fever. Specifically, the six patients with . , Hodgkin's disease had recorded rectal temperatures of less than 37.5°C on each of the 5 days before the determination of plasma hyproprotein. Also, with the exception of those patients included under Advanced Renal Disease, there was no evidence of renal functional impairment as indicated by urinalysis, and either blood urea nitrogen or plasma creatinine level. Patients with several other specific diseases also exhibited elevated levels; the most conclusive data were obtained in hyperthyroidism, Paget's disease, Sjogren's syndrome, and Ehlers-Danlos syndrome with severe skin involvement (Table II) . IV. Relation between urine hydroxyproline and plasma hyproprotein. Two patients with Hodgkin's disease were placed on a hydroxyprolinefree diet and 24-hour urine collections and serial 10-ml blood samples were obtained for 6 days. Daily total urinary hydroxyproline and plasma ?4 18, hyproprotein levels are shown in Figure 3 . These data demonstrate that a normal level of excretion of hydroxyproline peptides in urine may occur in the presence of distinctly elevated levels of plasma hyproprotein.
Discussion Previous studies of collagen metabolism in the intact subject have been based primarily on the measurement of hydroxyproline in dialyzable peptides in the urine (5) and in protein-free filtrates of plasma (6) . Elevated urine hydroxyproline levels, up to 5 to 10 times the levels of normal adults, have been observed in normal individuals during phases of rapid growth (e.g., adolescence) and in several disease states, including acromegaly, hyperthyroidism, hyperparathyroidism, Paget's disease of bone, Marfan's syndrome, "active" scleroderma, and Klinefelter's syndrome (5, 7). Hydroxyproline peptides are presumed to reflect collagen degradation (8, 9) . Thus, comparison of the present data with the findings of studies on peptide-bound hydroxyproline in urine may afford some basis for determining the place of hyproprotein in the over-all scheme of collagen metabolism.
In contrast to the situation with urinary peptides, the levels of plasma hyproprotein are remarkably constant through a wide age range in normal individuals. Although distinctly higher levels of hyproprotein were observed in subjects aged 2 weeks to 2 years, the values obtained in adolescents were in the same general range as noted in adults. A lack of correlation between plasma hyproprotein and urinary hydroxyproline was observed also in the two patients with Hodgkin's disease, in whom levels of the former were considerably elevated while urinary hydroxyproline excretion was normal. On the other hand, slight elevations of hyproprotein were noted in some subjects with conditions in which elevated urinary hydroxyproline has been observed; these included patients with Paget's disease, hyperthyroidism, acromegaly, and scleroderma.
It Regardless of the nature of plasma hyproprotein, the abnormalities observed in disease states merit additional comment. Most of the elevations of plasma hyproprotein were associated with active or acute phases of disease, and it can be argued that these changes are similar to those observed with "acute phase reactants" such as fibrinogen, haptoglobin, and C-reactive protein. Since none of these substances was measured, this question is unanswered for the present. The highest and most consistent elevations have been observed in Hodgkin's disease, perhaps as a reflection of the collagenous element of this "fibroproliferative" disorder. In preliminary studies we have found that serial determinations of hyproprotein levels may be helpful in assessing the activity of Hodgkin's disease and responses to therapy. Similar reasoning and application may be possible for a number of the disorders outlined in Table II , including the sarcomatous neoplasms and the chronic inflammatory disorders.
If current assumptions concerning the significant relationship between hydroxyproline and collagen are correct, plasma hyproprotein represents an easily accessible and hitherto unstudied parameter of collagen metabolism. Because of its larger molecular size, this protein seems more closely related to the intact collagen fibril than is the case with previously studied metabolites of collagen. The variety of disorders in which alterations were observed suggests that involvement of collagen is more common than histopathologic studies have indicated and that under some circumstances plasma hyproprotein may be a more sensitive index of collagen metabolism than those previously studied.
Summary
Measurements of a hydroxyproline-containing, collagen-like protein (hyproprotein) in human plasma have been carried out in 101 normal persons ranging from newborn to 93 years of age and in 146 patients with a variety of diseases. In comparison with reported levels of hydroxyproline peptide excretion, plasma hyproprotein levels were found to be remarkably constant in normal subjects regardless of age, although levels in infants and adolescents are slightly higher than in children and adults. Elevated levels of plasma hyproprotein were seen in association with a number of disorders, the most striking being in Hodgkin's disease. The possible significance of this protein as an index of collagen metabolism is discussed.
